#controlledsubstancesact

  1. The Court Case That Could Change The Cannabis Industry Forever And How It Affects Rescheduling

    By Nicolás Jose Rodriguez A groundbreaking court case filed in Massachusetts against U.S. Attorney General Merrick Garland has captured the attention of the cannabis industry, promising to potentially reshape its future. The lawsuit challenges the federal government's classificatio
  2. Washington Doctor Vs. DEA For Lawful Use Of Psilocybin To Treat Terminally Ill Patients

    By Lara Goldstein A protracted legal battle led by Dr. Sunil Aggarwal and the Advanced Integrative Medical Science Institute (AIMS) against the Drug Enforcement Administration (DEA) for the latter's refusal to allow psilocybin treatment for terminally-ill patients has taken anothe
  3. Lawsuit Against US Attorney General And Record Cannabis Sales, Two Of Many 2023 Marijuana Milestones

    By Nina Zdinjak Though another year has slipped away without cannabis legalization or rescheduling on the federal level, the SAFE Banking Act still lingering somewhere in the halls of Congress and with precious few long-anticipated reforms enacted…other milestones took place in 20
  4. DEA Renews Effort To Place 2 Psychedelics In Strictest Drug Category

    By Lara Goldstein On Dec. 12, the Drug Enforcement Administration (DEA) and the Justice Department jointly released a proposed rule to place 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I under the federal Controlled Substances Act
  5. Federal Agency Announces New Cannabis Research Center To Alleviate Study Barriers, Regulatory Hurdles

    By Maureen Meehan The National Institutes of Health (NIH) is taking a significant step forward in advancing cannabis research by establishing a Resource Center for Cannabis and Cannabinoid Research . The center will serve as a central hub for researchers to access resources, guidanc
  6. Two 15-Year Sentences Illustrate the Ugly Interaction of Drug and Gun Laws

    By Jacob Sullum On Monday, the U.S. Supreme Court heard two cases, Brown v. United States and Jackson v. United States , involving men who were each sentenced to 15 years in federal prison for possessing a firearm. Although the oral arguments focused on an arcane issue of statutory
  7. Cross-Political Coalition To Biden: Deschedule Cannabis, Don't Just Rebrand Federal Criminalization

    By Maureen Meehan Two political coalitions, the left-leaning Marijuana Justice Coalition and the conservative Cannabis Freedom Alliance have united to urge President Joe Biden to fulfill his campaign promise by removing marijuana from the federal Controlled Substances Act (CSA). T
  8. Congressional Research Service Foresees Potential DEA Endorsement Of Marijuana Rescheduling

    By Joana Scopel On August 29, 2023, the U.S. Department of Health and Human Services (HHS) recommended the DEA reclassify marijuana and move it from Schedule I to Schedule III, following a review by the Food and Drug Administration (FDA), as part of a process initiated by Presiden
  9. Health Dept Decision To Move Cannabis To Lower-Risk Category: Bull Case Narrative For The Industry

    By Nicolás Jose Rodriguez Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions. On the day following the report, MSOS